# A Study of EDG-15400 in Healthy Adults

> **NCT07177066** · PHASE1 · RECRUITING · sponsor: **Edgewise Therapeutics, Inc.** · enrollment: 108 (estimated)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** EDG-15400
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07177066
- **Lead sponsor:** Edgewise Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-20
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07177066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07177066, "A Study of EDG-15400 in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07177066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*